相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Helicase-Like Transcription Factor HLTF and E3 Ubiquitin Ligase SHPRH Confer DNA Damage Tolerance through Direct Interactions with Proliferating Cell Nuclear Antigen (PCNA)
Mareike Seelinger et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Population Genomic Screening of All Young Adults in a Health-Care System
Lei Zhang et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2020)
A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2
Ana F. Best et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer
Petra Kleiblova et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
Hsiao-Mei Lu et al.
JAMA ONCOLOGY (2019)
The identification of pathogenic variants in BRCA1/2 negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of FANCM pathogenic variants
Stephanie Schubert et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia
Ana Krivokuca et al.
JOURNAL OF HUMAN GENETICS (2019)
Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?
Agostina Stradella et al.
JOURNAL OF MEDICAL GENETICS (2019)
Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases
Robert D. Morgan et al.
JOURNAL OF MEDICAL GENETICS (2019)
Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes
James Whitworth et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real-life experience
K. Rust et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families
Laurent Castera et al.
GENETICS IN MEDICINE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes
Jana Soukupova et al.
PLOS ONE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer genetics, precision prevention and a call to action
Clare Turnbull et al.
NATURE GENETICS (2018)
Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review
David W. Hein et al.
PHARMACOGENETICS AND GENOMICS (2018)
Germline pathogenic variants identified in women with ovarian tumors
Natalie J. Carter et al.
GYNECOLOGIC ONCOLOGY (2018)
Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings
Sandra Bonache et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 Patients
Magdalena Koczkowska et al.
CANCERS (2018)
Reversal of Bowel Obstruction With Platinum-Based Chemotherapy and Olaparib in Recurrent, Short Platinum-Free Interval, RAD51C Germline Mutation-Associated Ovarian Cancer
Natalie Y. L. Ngoi et al.
JCO PRECISION ONCOLOGY (2018)
Significant Tumor Response to the Poly (ADP-ribose) Polymerase Inhibitor Olaparib in Heavily Pretreated Patient With Ovarian Carcinosarcoma Harboring a Germline RAD51D Mutation
Elias A. Chandran et al.
JCO PRECISION ONCOLOGY (2018)
Fanconi anaemia and cancer: an intricate relationship
Grzegorz Nalepa et al.
NATURE REVIEWS CANCER (2018)
NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer
Angela George et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
Jenna Lilyquist et al.
GYNECOLOGIC ONCOLOGY (2017)
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
Philipp Harter et al.
PLOS ONE (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study
Inga Plaskocinska et al.
JOURNAL OF MEDICAL GENETICS (2016)
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations
Paul D. P. Pharoah et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations
Paul D. P. Pharoah et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Multilocus Inherited Neoplasia Alleles Syndrome A Case Series and Review
James Whitworth et al.
JAMA ONCOLOGY (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer
Mohammad R. Akbari et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer: A Preplanned Retrospective Analysis of Outcomes by BRCA Status in a Randomised Phase 2 Trial EDITORIAL COMMENT
Jonathan Ledermann et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Efrat Gabai-Kapara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint
Petra Kleiblova et al.
JOURNAL OF CELL BIOLOGY (2013)
Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
Elise Ruark et al.
NATURE (2013)
Hereditary gynecological tumors associated with Peutz-Jeghers syndrome
Kouji Banno et al.
ONCOLOGY LETTERS (2013)
Germline RAD51C mutations confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2012)
Arylamine N-Acetyltransferase 1: A Novel Drug Target in Cancer Development
Neville J. Butcher et al.
PHARMACOLOGICAL REVIEWS (2012)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Keren Levanon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers:: a prospective cohort study
SM Domchek et al.
LANCET ONCOLOGY (2006)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Genomic medicine - Hereditary colorectal cancer
HT Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer
P Watson et al.
GYNECOLOGIC ONCOLOGY (2001)
分享论文
